Center for Scientific Review; Amended Notice of Meeting, 25289 [2019-11328]
Download as PDF
<![CDATA[
khammond on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 84, No. 105 / Friday, May 31, 2019 / Notices
Users.’’ International Journal of Drug
Policy, vol. 33, pp. 23:37–44, 2012.
8. Bicket, M., Long, J., Pronovost, P., et al.,
‘‘Prescription Opioid Analgesics
Commonly Used After Surgery: A
Systematic Review.’’ JAMA Surgery, vol.
152, pp. 1066–1071, 2017 (available at
doi:10.1001/jamasurg.2017.0831,
published online August 2, 2017).
9. Howard, R., Fry, B., Gunaseelan, V., et al.,
‘‘Association of Opioid Prescribing with
Opioid Consumption After Surgery in
Michigan.’’ JAMA Surgery, vol. 154, p.
e184234, 2019 (available at doi:10.001/
jamasurg.2018.4234, published online
November 7, 2018).
10. Thiels, C., Ubl, D., Yost, K., et al.,
‘‘Results of a Prospective, Multicenter
Initiative Aimed at Developing OpioidPrescribing Guidelines After Surgery.’’
Annals of Surgery, vol. 268, pp. 457–468,
2018 (available at doi:10.1097/
SLA.0000000000002919).
11. Mundkur, M., Meyer, T., Menzin, T., et
al., ‘‘Estimating the Optimal Duration of
Initial Opioid Analgesic Prescriptions in
Post-Surgical Populations Using FDA’s
Sentinel Distributed Database.’’
Pharmacoepidemiology and Drug Safety,
S2: Abstracts of the 34th International
Conference on Pharmacoepidemiology &
Therapeutic Risk Management, Abstract
#392, vol. 27, p. 181 (available at
doi:10.1002/pds.4629).
12. Steiner, C.A., Karaca, Z., Moore, B.J., et
al., ‘‘Surgeries in Hospital-Based
Ambulatory Surgery and Hospital
Inpatient Settings, 2014.’’ HCUP
Statistical Brief #223, 2017 (available at
www.hcup-us.ahrq.gov/reports/
statbriefs/sb223-Ambulatory-InpatientSurgeries-2014.pdf).
13. Mundkur, M., unpublished data.
* 14. Mundkur, M., Franklin, J., Abdia, Y., et
al., ‘‘Days’ Supply of Initial Opioid
Analgesic Prescriptions and Additional
Fills for Acute Pain Conditions Treated
in the Primary Care Setting—United
States, 2014.’’ Morbidity and Mortality
Weekly Report, vol. 68, pp. 140–143,
2019.
* 15. Dowel, D., Haegerich, T., and Chou, R.,
‘‘CDC Guideline for Prescribing Opioids
for Chronic Pain—United States, 2016.’’
Morbidity and Mortality Recommended
Weekly Report, vol. 65(1), pp. 1–49,
2016.
16. Opiate Prescribing Engagement Network,
‘‘Emergency Department Prescribing
Recommendations’’ (available at https://
michigan-open.org/emergencydepartment-prescribingrecommendations/), accessed January 5,
2019.
17. Ohio Opiate Action Team, ‘‘Ohio
Guidelines for Emergency and Acute
Care Facility Opioid and Other
Controlled Substances (OOCS)
Prescribing’’ (available at https://
mha.ohio.gov/Portals/0/assets/
Initiatives/GCOAT/Guidelines-ED-AcuteCare.pdf), accessed January 5, 2019.
18. New York City Emergency Department,
‘‘Discharge Opioid Prescribing
Guidelines’’ (available at https://
www1.nyc.gov/assets/doh/downloads/
VerDate Sep<11>2014
16:42 May 30, 2019
Jkt 247001
pdf/basas/opioid-prescribingguidelines.pdf), accessed January 5,
2019.
19. Thiels, C., Ubl, D., Yost, K., et al.,
‘‘Results of a Prospective, Multicenter
Initiative Aimed at Developing OpioidPrescribing Guidelines After Surgery.’’
Annals of Surgery, vol. 268, pp. 457–468,
2018.
20. The Regents of the University of
Michigan, ‘‘Opioid Prescribing
Recommendations for Surgery’’
(available at https://
opioidprescribing.info/), last updated
April 11, 2019, accessed April 17, 2019.
21. Overton, H., Hanna, M., Bruhn, W., et al.,
‘‘Opioid-Prescribing Guidelines for
Common Surgical Procedures: An Expert
Panel Consensus.’’ Journal of the
American College of Surgeons, vol. 227,
pp. 411–418, 2018.
Dated: May 24, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–11283 Filed 5–30–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Lung Cellular,
Molecular, and Immunobiology Study
Section, June 4, 2019, 08:00 a.m. to June
5, 2019, 03:00 p.m., Hilton Baltimore
Inner Harbor, 401 W Pratt Street,
Baltimore, MD 21201, which was
published in the Federal Register on
April 16, 2019, 84 FR PG 15624.
The meeting location is being changed
to Hilton Baltimore Inner Harbor, 401 W
Pratt Street, Baltimore, MD 21201.
Meeting dates remain the same. The
meeting is closed to the public.
Dated: May 24, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–11328 Filed 5–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
25289
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
NIMH Pilot Effectiveness Trials for
Treatment, Preventive, and Services
Interventions (R34).
Date: June 18, 2019.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892, 301–443–9699,
bursteinme@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
NCDDG & First in Human and Early Stage
Clinical Trials for Psychiatric Disorders.
Date: June 18, 2019.
Time: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892, 301–443–1606,
charlesvi@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Building in vivo Preclinical Assays of Circuit
Engagement for Application in Therapeutic
Development (R01).
Date: June 25, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6149, MSC 9608,
Bethesda, MD 20892, 301–443–4525,
steinerr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
E:\FR\FM\31MYN1.SGM
31MYN1
]]>Agencies
[Federal Register Volume 84, Number 105 (Friday, May 31, 2019)]
[Notices]
[Page 25289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-11328]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Lung
Cellular, Molecular, and Immunobiology Study Section, June 4, 2019,
08:00 a.m. to June 5, 2019, 03:00 p.m., Hilton Baltimore Inner Harbor,
401 W Pratt Street, Baltimore, MD 21201, which was published in the
Federal Register on April 16, 2019, 84 FR PG 15624.
The meeting location is being changed to Hilton Baltimore Inner
Harbor, 401 W Pratt Street, Baltimore, MD 21201. Meeting dates remain
the same. The meeting is closed to the public.
Dated: May 24, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-11328 Filed 5-30-19; 8:45 am]
BILLING CODE 4140-01-P
